Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 784-787, 2007. First published March 1, 2007; 10.1373/clinchem.2006.081570
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.081570v1
53/4/784    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiedmeyer, H.-M.
Right arrow Articles by Palmer, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiedmeyer, H.-M.
Right arrow Articles by Palmer, J. P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2007;53:784-787.)
© 2007 American Association for Clinical Chemistry, Inc.


Technical Briefs

International Comparison of C-Peptide Measurements

Hsiao-Mei Wiedmeyer1, Kenneth S. Polonsky2, Gary L. Myers3, Randie R. Little1,a, Carla J. Greenbaum4, David E. Goldstein1 and Jerry P. Palmer5

1 Departments of Pathology & Anatomical Sciences and Child Health, University of Missouri-Columbia School of Medicine, Columbia, MO; 2 Department of Medicine, Washington University School of Medicine, St. Louis, MO; 3 Centers for Disease Control and Prevention, Division of Environmental Health Laboratory Sciences, Centers for Environmental Health (F25), Chamblee, GA; 4 Benaroya Research Institute, Seattle, WA; 5 University of Washington and VA Medical Center, Seattle, WA;

aaddress correspondence to this author at: Diabetes Diagnostic Laboratory, M767, Departments of Pathology & Anatomical Sciences and Child Health, University of Missouri School of Medicine, 1 Hospital Dr. Columbia, MO 65212; fax 573-884-8823, e-mail: LittleR{at}health.missouri.edu


Abstract

Background: C-peptide measurement has been widely used as a marker of insulin secretion in patients with diabetes. We assessed the comparability of C-peptide results obtained with different methods and by different laboratories and determined whether C-peptide results could be harmonized by normalization with a WHO reference reagent or with plasma.

Methods: We sent 16 different heparin plasma samples to 15 laboratories in 7 countries. The samples were analyzed with 10 different assay methods. A WHO C-peptide standard was also sent to each laboratory and used to determine the feasibility of normalizing results. To assess the impact of calibrator matrix on the comparability of results, we also used the mean results of all laboratories for 4 of the samples to normalize the remaining sample results.

Results: Between-laboratory variability increased with increasing C-peptide concentrations. Normalization of results with WHO reference reagents did not improve comparability, but normalization with samples significantly improved comparability among laboratories and methods. The 95% confidence interval estimate for the SD for the lab/method effect (0.0–0.061) using sample-normalized values did not overlap with the 95% CI estimate with the raw data (0.090–0.225).

Conclusions: C-peptide results generated by different methods and different laboratories do not always agree, especially at higher concentrations of C-peptide. These data support the concept of using a single laboratory for multisite studies and support efforts to harmonize C-peptide measurements by use of calibrators prepared in the sample matrix.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
P. E.M. De Pauw, I. Vermeulen, O. C. Ubani, I. Truyen, E. M.F. Vekens, F. T. van Genderen, J. W. De Grijse, D. G. Pipeleers, C. Van Schravendijk, and F. K. Gorus
Simultaneous Measurement of Plasma Concentrations of Proinsulin and C-Peptide and Their Ratio with a Trefoil-Type Time-Resolved Fluorescence Immunoassay
Clin. Chem., December 1, 2008; 54(12): 1990 - 1998.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. E. Manley, S. D. Luzio, I. M. Stratton, T. M. Wallace, and P. M.S. Clark
Preanalytical, Analytical, and Computational Factors Affect Homeostasis Model Assessment Estimates
Diabetes Care, September 1, 2008; 31(9): 1877 - 1883.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. R. Little, C. L. Rohlfing, A. L. Tennill, R. W. Madsen, K. S. Polonsky, G. L. Myers, C. J. Greenbaum, J. P. Palmer, E. Rogatsky, and D. T. Stein
Standardization of C-Peptide Measurements
Clin. Chem., June 1, 2008; 54(6): 1023 - 1026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.